General Motors Company (GM)vsVertex Pharmaceuticals Inc (VRTX)
GM
General Motors Company
$76.61
+0.05%
CONSUMER CYCLICAL · Cap: $71.43B
VRTX
Vertex Pharmaceuticals Inc
$454.97
+1.42%
HEALTHCARE · Cap: $113.95B
Smart Verdict
WallStSmart Research — data-driven comparison
General Motors Company generates 1442% more annual revenue ($185.02B vs $12.00B). VRTX leads profitability with a 32.9% profit margin vs 1.5%. VRTX appears more attractively valued with a PEG of 2.19. VRTX earns a higher WallStSmart Score of 66/100 (B-).
GM
Hold44
out of 100
Grade: D
VRTX
Strong Buy66
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-258.9%
Fair Value
$22.24
Current Price
$76.61
$54.37 premium
Margin of Safety
+36.5%
Fair Value
$716.04
Current Price
$454.97
$261.07 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Large-cap with strong market position
Generating 5.7B in free cash flow
Keeps 33 of every $100 in revenue as profit
Strong operational efficiency at 39.6%
Safe zone — low bankruptcy risk
Large-cap with strong market position
Every $100 of equity generates 23 in profit
Conservative balance sheet, low leverage
Areas to Watch
ROE of 4.3% — below average capital efficiency
1.5% margin — thin
Weak financial health signals
Expensive relative to growth rate
Expensive relative to growth rate
Moderate valuation
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : GM
The strongest argument for GM centers on Price/Book, Market Cap, Free Cash Flow.
Bull Case : VRTX
The strongest argument for VRTX centers on Profit Margin, Operating Margin, Altman Z-Score. Profitability is solid with margins at 32.9% and operating margin at 39.6%.
Bear Case : GM
The primary concerns for GM are Return on Equity, Profit Margin, Piotroski F-Score. Thin 1.5% margins leave little buffer for downturns.
Bear Case : VRTX
The primary concerns for VRTX are PEG Ratio, P/E Ratio, Piotroski F-Score.
Key Dynamics to Monitor
GM profiles as a value stock while VRTX is a mature play — different risk/reward profiles.
GM carries more volatility with a beta of 1.36 — expect wider price swings.
VRTX is growing revenue faster at 9.5% — sustainability is the question.
GM generates stronger free cash flow (5.7B), providing more financial flexibility.
Bottom Line
VRTX scores higher overall (66/100 vs 44/100), backed by strong 32.9% margins. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
General Motors Company
CONSUMER CYCLICAL · AUTO MANUFACTURERS · USA
General Motors Company (GM) is an American multinational corporation headquartered in Detroit, Michigan that designs, manufactures, markets, and distributes vehicles and vehicle parts, and sells financial services, with global headquarters in Detroit's Renaissance Center.
Vertex Pharmaceuticals Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.
Compare with Other AUTO MANUFACTURERS Stocks
Want to dig deeper into these stocks?